Occam Places Geoff McDonough as CEO of Generation Bio
Generation Bio, a Casdin/Atlas investment, is a now public gene therapy company focused on providing treatment for patients living with rare, genetic diseases.
In late 2019, Occam was hired by Atlas Venture to build a complete C-level leadership team around the company’s platform. One of our placements was Geoff McDonough, MD as CEO along with a CFO who later took the company public, raising $125M in the process. Previously, McDonough served as the CEO of Swedish biopharmaceutical, Sobi, following a lengthy tenure at Genzyme.
View recent Placements
.jpg)
.jpg)
.jpg)
.jpg)
DISCOVER OCCAM GLOBAL
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.
Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.